SANA

Sana Biotechnology Inc. (SANA) | Rumor.io

Sana Biotechnology

SANA

Attention (50-day avg)0%

Attention rank (50-day avg)#1,836

Bullish sentiment (50-day avg)78%

Price to earnings ratio-3.06

Market capitalization877.1M

Earnings per share-0.75

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)-244.2M

Social

What share of all stock conversation is about SANA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% -0.01

Jun 16

Sana Biotechnology, Inc. ($SANA) is close to being listed on the Moonshot Top 100 Leaderboard, with multiple posts indicating it needs fewer than 200 votes to achieve this.
The listing would be significant for community growth and could lead to a price increase, with some posters stating they are holding heavy on the stock.
The exact number of votes needed varies across posts, but all agree that voting is crucial to reaching the Moonshot listing goal.

Generated by AI

Sentiment

Of the messages about SANA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	50% -33.87	91.48% +9.4
Bearish	—	0%	50% +33.87	8.52% -9.4

Bullish· Jun 16

Sana Biotechnology, Inc. ($SANA) is close to getting listed on Moonshot, with only a few votes needed to reach the top 100 leaderboard.
Listing on Moonshot could have a significant impact on the company, with potential for community growth and increased visibility.
Investors are holding heavy on $SANA, expecting a price surge once it lists on Moonshot.

Bearish· Oct 15

The author believes that Sana Biotechnology, Inc. will experience a significant short squeeze, leading to a price increase.
The company's stock is seen as weak, with the author starting a put position and expecting the price to decline.
The author is bearish on the company's stock due to concerns about its outstanding shares and the impact of Eric Jackson's involvement, which they believe is driving up the price artificially.

Generated by AI

Topics

Of the messages about SANA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	70.85%
Earnings	—	—	0%	0.38%
Analysts	—	—	0%	1.32%
Controversies	—	—	0%	0.19%
Macro	—	—	0%	21.11%
Technical Analysis	—	—	0%	6.16%

Announcements· Nov 13

The United States Crypto Reserve (USCR) is expanding its ecosystem and moving forward with an airdrop to reward its community.
The airdrop is intended to support the USCR community, with the goal of building smarter and more decentralized financial systems.
$SANA is mentioned as part of the USCR ecosystem, but it is unclear what specific role Sana Biotechnology, Inc. plays in the USCR project.

Technical Analysis· Jan 8

$SANA is expected to retest $12 soon, with a potential short opportunity at $5.50.
A breakout above $6.40 with strong volume could push $SANA toward $7.00 or higher, while a failure to hold $5.50 may lead to further downside.
The stock is showing signs of a possible bull pennant, with extension targets at $7.40-$50+ and a potential move towards $10+.

Generated by AI

Community

Of the messages about SANA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	0%	95.48%	55.74%
Newcomers	—	100%	4.52%	44.26%

Regulars· Oct 16

The price of Sana Biotechnology, Inc. (SANA) stock is surging, with Eric Jackson calling it a potential 100-bagger.
The company is expected to file a BLA (biologics license application) for its SC451 program, which could lead to significant growth.
SANA is being considered a strong buy, with some analysts setting a price target and others discussing its potential for a monster squeeze, making it a promising investment opportunity.

Newcomers· Oct 16

Newcomers are focused on the potential of Sana Biotechnology's stock to rebound after a decline, with some seeing strong growth potential and a price target of $8.00.
The company's breakthrough CAR-T and in vivo cell therapy technology is being highlighted as a key factor in its recent surge, with some analysts seeing the potential for a 100-bagger.
The stock's momentum is being closely watched, with some seeing a potential breakout near $5.50 and others expecting a test of the $6.55 resistance level, as traders and investors continue to focus on the company's promising pipeline and potential for major breakthroughs.

Generated by AI

News

H.C. Wainwright Remains a Buy on Sana Biotechnology (SANA)

Detailed price information for Sana Biotechnology Inc (SANA-Q) from The Globe and Mail including charting and trades.

7d agoThe Globe and Mail

Sana Biotechnology at citigroup’s biopharma back to school summit 2026: diabetes push

19d agoInvesting.com

Sana Biotechnology at wells fargo healthcare conference: two programs near clinic

21d agoInvesting.com

Sana Biotechnology to Present at September 2026 Investor Conferences

SEATTLE, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in September. The presentations will feature a business overview and update. Sana will present at the 2026 Wells Fargo Healthcare Conference at 9:30 a.m. ET on Tuesday, September 8, 2026.Sana will present at Citi’s 2026 Biopharma Back-to-School Conf

28d agoYahoo Finance

Biotech Breakout: What's in focus after Moderna's cancer win? (MRNA:NASDAQ)

1mo agoSeeking Alpha

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)

Detailed price information for Sana Biotechnology Inc (SANA-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

Also Discussed

Investors talking about SANA also mention

#	Name	Attention
1	Century Therapeutics IncIPSC	0%0
2	Saul Centers, Inc.BFS	0%new
3	Organogenesis Holdings Inc. Class A Common StockORGO	0%new
4	GSD - WisdomTree Global SmallCap Dividend Fund	——
5	Syra Health Corp.SYRA	0%0
6	Beam Therapeutics IncBEAM	0.02%+0.02
7	Caribou Biosciences, Inc.CRBU	0%0
8	PennyMac Mortgage Investment TrustPMT	0.01%new
9	Armstrong World Industries Inc.AWI	0%new
10	Janus Henderson AAA CLO ETFJAAA	0%0

Sana Biotechnology Inc.

Healthcare
Biotechnology

Sana Biotechnology Inc. is a biotechnology company focused on creating and delivering engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms designed to address serious diseases with unmet treatment needs, including type 1 diabetes, B cell-mediated autoimmune diseases, oncology, and other immune-related conditions. Its work centers on modifying, replacing, or repairing cells to support next-generation therapeutic approaches, with research and development spanning cell therapy, gene delivery, and immune evasion technologies. Sana Biotechnology operates as a clinical-stage company and does not yet market approved commercial therapies, making its role in the market primarily centered on innovation, pipeline development, and translational research. Headquartered in Seattle, Washington, the company is part of the broader biotechnology sector, where engineered-cell platforms are an important area of active drug development.

Website

Location

188 East Blaine Street

Seattle, WA, 98102

United States

Social

What share of all stock conversation is about SANA?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% 0	0% -0.01

Jun 16

Sana Biotechnology, Inc. ($SANA) is close to being listed on the Moonshot Top 100 Leaderboard, with multiple posts indicating it needs fewer than 200 votes to achieve this.
The listing would be significant for community growth and could lead to a price increase, with some posters stating they are holding heavy on the stock.
The exact number of votes needed varies across posts, but all agree that voting is crucial to reaching the Moonshot listing goal.

Generated by AI

Sentiment

Of the messages about SANA that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	100%	50% -33.87	91.48% +9.4
Bearish	—	0%	50% +33.87	8.52% -9.4

Bullish· Jun 16

Sana Biotechnology, Inc. ($SANA) is close to getting listed on Moonshot, with only a few votes needed to reach the top 100 leaderboard.
Listing on Moonshot could have a significant impact on the company, with potential for community growth and increased visibility.
Investors are holding heavy on $SANA, expecting a price surge once it lists on Moonshot.

Bearish· Oct 15

The author believes that Sana Biotechnology, Inc. will experience a significant short squeeze, leading to a price increase.
The company's stock is seen as weak, with the author starting a put position and expecting the price to decline.
The author is bearish on the company's stock due to concerns about its outstanding shares and the impact of Eric Jackson's involvement, which they believe is driving up the price artificially.

Generated by AI

Topics

Of the messages about SANA that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	100%	70.85%
Earnings	—	—	0%	0.38%
Analysts	—	—	0%	1.32%
Controversies	—	—	0%	0.19%
Macro	—	—	0%	21.11%
Technical Analysis	—	—	0%	6.16%

Announcements· Nov 13

The United States Crypto Reserve (USCR) is expanding its ecosystem and moving forward with an airdrop to reward its community.
The airdrop is intended to support the USCR community, with the goal of building smarter and more decentralized financial systems.
$SANA is mentioned as part of the USCR ecosystem, but it is unclear what specific role Sana Biotechnology, Inc. plays in the USCR project.

Technical Analysis· Jan 8

$SANA is expected to retest $12 soon, with a potential short opportunity at $5.50.
A breakout above $6.40 with strong volume could push $SANA toward $7.00 or higher, while a failure to hold $5.50 may lead to further downside.
The stock is showing signs of a possible bull pennant, with extension targets at $7.40-$50+ and a potential move towards $10+.

Generated by AI

Community

Of the messages about SANA, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	0%	95.48%	55.74%
Newcomers	—	100%	4.52%	44.26%

Regulars· Oct 16

The price of Sana Biotechnology, Inc. (SANA) stock is surging, with Eric Jackson calling it a potential 100-bagger.
The company is expected to file a BLA (biologics license application) for its SC451 program, which could lead to significant growth.
SANA is being considered a strong buy, with some analysts setting a price target and others discussing its potential for a monster squeeze, making it a promising investment opportunity.

Newcomers· Oct 16

Newcomers are focused on the potential of Sana Biotechnology's stock to rebound after a decline, with some seeing strong growth potential and a price target of $8.00.
The company's breakthrough CAR-T and in vivo cell therapy technology is being highlighted as a key factor in its recent surge, with some analysts seeing the potential for a 100-bagger.
The stock's momentum is being closely watched, with some seeing a potential breakout near $5.50 and others expecting a test of the $6.55 resistance level, as traders and investors continue to focus on the company's promising pipeline and potential for major breakthroughs.

Generated by AI

Sana Biotechnology

Social

Jun 16

Bullish· Jun 16

Bearish· Oct 15

Announcements· Nov 13

Technical Analysis· Jan 8

Regulars· Oct 16

Newcomers· Oct 16

H.C. Wainwright Remains a Buy on Sana Biotechnology (SANA)

Sana Biotechnology at citigroup’s biopharma back to school summit 2026: diabetes push

Sana Biotechnology at wells fargo healthcare conference: two programs near clinic

Sana Biotechnology to Present at September 2026 Investor Conferences

Biotech Breakout: What's in focus after Moderna's cancer win? (MRNA:NASDAQ)

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)

Also Discussed

Sana Biotechnology Inc.

Company Information

Location

H.C. Wainwright Remains a Buy on Sana Biotechnology (SANA)

Sana Biotechnology at citigroup’s biopharma back to school summit 2026: diabetes push

Sana Biotechnology at wells fargo healthcare conference: two programs near clinic

Sana Biotechnology to Present at September 2026 Investor Conferences

Biotech Breakout: What's in focus after Moderna's cancer win? (MRNA:NASDAQ)

Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE), AgomAb Therapeutics NV ADR (AGMB) and Sana Biotechnology (SANA)

Also Discussed

Social

Jun 16

Bullish· Jun 16

Bearish· Oct 15

Announcements· Nov 13

Technical Analysis· Jan 8

Regulars· Oct 16

Newcomers· Oct 16